Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
Antibiotic treatments against lung infections by the bacteria Mycobacterium abscessus can improve the outcome of patients with bronchiectasis, according to a new study. The case study “Eradication Of Mycobacterium ... Read more
Results from two Phase 3 studies show that Pulmaquin (inhaled ciprofloxacin) may be a safe and effective therapy for patients with non-cystic fibrosis bronchiectasis (non-CF BE) with chronic lung ... Read more
A recent study review published in the Chinese Medical Journal highlighted associations between bronchiectasis and chronic obstructive pulmonary disease (COPD). The review, “Bronchiectasis As A Comorbidity Of Chronic Obstructive Pulmonary ... Read more
Non-cystic fibrosis (CF) bronchiectasis may develop as the primary manifestation of endobronchial sarcoidosis, a disease that affects the lungs’ bronchi (the tiny sacs that make up the lungs, where ... Read more
Bayer will present data from current trials in non-cystic fibrosis (non-CF) bronchiectasis and pulmonary arterial hypertension at the American College of Chest Physicians (CHEST 2016) Oct. 22-26 in Los Angeles. “Our data reflects ... Read more
Aradigm Corporation announced a collaboration with the University of Sydney to develop a program of advanced nanotechnologies to treat bacterial and fungal biofilms — aggregates of pathogens that adhere ... Read more